KCT0001989已完成未知
An Open-label, Randomized, Multiple-dose, Crossover Study to Evaluate the Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects with Androgenic Alopecia
Dong-A ST0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 65(Year)（—）
- 性别
- Male
入选标准
- •Male, aged between 19 and 65 years, clinically healthy
- •-BMI between 18.5kg/m2 and 27kg/m2
- •-Clinical history of Androgenic Alopecia
排除标准
- •-Subject has any dermatological disorders of the scalp
- •-Subject has a history of hair transplants, hair weaves
- •-Subject has hypersensitivity to previously prescribed minoxidil or finasteride
- •-Subject who is considered inappropriate to participate in the study due to any conditions including screening results at the investigator's discretion
研究者
相似试验
尚未招募
1 期
Phase-I bridging study of TRC041266 Powder in healthy human subjects.CTRI/2020/04/024708Dr Sanjay Sharma
招募中
不适用
Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male VolunteersKCT0000176Yonsei University Health System, Severance Hospital36
尚未招募
1 期
A Multiple-dose, Randomized, Open-label, Crossover Bioequivalence Study of Generic Trimetazidine Dihydrochloride 80 mg Prolonged-release Capsules and Reference Product in Healthy Thai Volunteers under Fed ConditionsHealthy subjectsBioequivalence Trimetazidine Dihydrochloride 80 mgTCTR20240529007Bio-innova Co., Ltd.34
尚未招募
1 期
A Multiple-dose, Randomized, Open-label, Crossover Bioequivalence Study of Generic Desvenlafaxine 50 mg Extended-release Tablets and Reference Product (Pristiq) in Healthy Thai Volunteers under Fasting ConditionsHealthy subjectsBioequivalence Desvenlafaxine 50 mgTCTR20240322003Bio-innova Co., Ltd.30
已完成
不适用
A Randomized, open-label, multiple-dose, crossover phase I clinical study to evaluate DW1029M influence the pharmacokinetic profiles of Linagliptin after oral administration in healthy male volunteerEndocrine, nutritional and metabolic diseaseKCT0001326Dong Hwa Pharm12